4,397 karma · joined March 19, 2010
isaachodes@gmail.com
Would you mind sharing more information about how you found that list (esp for a given zip), and how you think they tied that information to an address? My email is in my profile, if you wouldn't mind reaching out.
"Finland has actually reversed course on that front this year, adopting rules that threaten to cut benefits for jobless people unless they actively look for work or engage in job training."
* Steve Rosenberg's a respected expert in the field
* Adoptive T cell therapy (ACT) of TIL (tumor-infiltrating lymphocytes) T cells specific for a (common) KRAS mutation (G12D)
* Culture/expand TILs, use tandem-minigenes to narrow down most reactive (to in silico ID mutations) TILs, then use synthetic peptides on the mutations encoded in the TMG that elicits largest response to find which epitopes in particular were being reacted to.
* 6 tumors eradicated, 7th shrunk but recurred (had to be resected, patient has no disease 4 months later); 7th had lost the HLA-C allele that the TCRs were specific to
* The supplementary materials/methods were pretty interesting (very technical)
[1] T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer http://www.nejm.org/doi/full/10.1056/NEJMoa1609279
This isn't ready for in vivo use yet due to off-target effects (CAS9 is a very permissive protein that often binds to the wrong part of the DNA).
In the US, Carl June's group at U Penn is working on editing adoptive, engineered CAR T cells for cancer therapy, going into clinical trials. They're probably bummed to have been scooped (first to do an adoptive CRISPR engineered T cell transfer), though their work is certainly more clinically relevant than Lu's.
1. Some knowledge is shared in journals; most knowledge isn't published until years after it's established. Much is never published, and is learned through word of math, and institutionally encoded. MD Anderson is world-renowned for being a center for excellence in cancer care.
2. Doctors don't read every article published in every journal related to their work. Even if they did, or read much of it, synthesizing into practice is a very different (and difficult) matter. Many of them don't read at all.
3. Why would MDs want to be send worldwide? And why would MD Anderson want to send them all over? Who pays for this? How can a doctor affect change in a large hospital system?
We’re a team of software developers and data scientists working to understand and improve how the immune system battles cancer. We're looking for (1) a senior machine learning specialist and (2) a senior development operations engineer.
1. Both cancer and the immune system are complex collections of cells whose interactions are difficult to predict. If you have done research in a top deep learning lab and have built and deployed models used in a high-value application, your skills could improve outcomes for patients enrolled in clinical trials of personalized cancer vaccines and combination immunotherapies.
2. The ideal candidate will have installed and serviced server and network hardware in a data center, written software to install, configure, and monitor production services, structured the build and release process of high-quality open source software, and secured and governed petabytes of data. We recognize that it’s rare to find an individual with experience in all four of these domains, however, so we are happy to hear from anyone with strong skills in one or two domains and an interest in learning more about and having responsibility for the rest.
Check out the job descriptions for more information, and send us an email! http://www.hammerlab.org/jobs/